Tag: neuroinflammation
-
Inflammasome Proteins Offer New Path in Pediatric Traumatic Brain Injury Assessment
Breakthrough in Pediatric TBI Evaluation: Biomarkers ASC and caspase-1 A new study published in Nature Pediatric Research highlights a promising biomarker-based approach to assessing pediatric traumatic brain injury (TBI). Led by Dr. Jennifer Muñoz Pareja, the research examines serum inflammasome proteins ASC and caspase-1, revealing that their levels rise significantly in children with TBI and…
-
Study Identifies New Approach to Protect the Brain During Radiation Therapy
Overview: A New Strategy to Shield the Brain During Radiation Cancer survivors often face cognitive challenges after treatment. In brain cancer, cranial radiation therapy is a standard lifesaving intervention, but it can cause lasting problems with memory, attention, and executive function. A recent experimental study from the University of California, Irvine, led by Munjal Acharya,…
-
New approach protects the brain from radiation-induced cognitive decline
New research offers a targeted safeguard for brain cancer patients undergoing radiation therapy For many cancer survivors, the battle isn’t over once tumors are treated. Cognitive challenges—trouble with memory, attention, and concentration—can persist after cranial radiation therapy. In brain cancer patients, up to 70% report some form of cognitive impairment, a burden that affects independence…
-
Against All Odds: The Seattle Man Defying Early-Onset Alzheimer’s Fate
Against All Odds: A Man Defies a Genetic Fate Doug Whitney, a 76-year-old retiree from Seattle, carries a rare genetic mutation that has historically forecast severe, early-onset Alzheimer’s disease. Yet, decades after the predicted onset, Whitney remains cognitively healthy. His story—shared with scientists and researchers who call him a “scientific unicorn”—is reshaping conversations about genetic…
-
Investigating cannabidiol’s role in combating Alzheimer’s-related neuroinflammation
Background: the inflammation link in Alzheimer’s disease Alzheimer’s disease is commonly discussed in terms of plaques and tangles, but neuroinflammation is increasingly recognized as a driving force in its progression. Chronic immune activation within the brain can damage neurons and contribute to cognitive decline. Cannabidiol (CBD), a non-psychoactive component of cannabis, has demonstrated anti-inflammatory properties…
-
Cannabidiol Shows Promise in Reducing Alzheimer’s-Related Neuroinflammation in Mouse Model
Overview: CBD as a potential anti-inflammatory strategy for Alzheimer’s disease Neuroinflammation is increasingly recognized as a central driver of neuronal damage in Alzheimer’s disease (AD). While the classic hallmarks of AD—amyloid plaques and tau tangles—have guided much research, chronic immune activation within the brain also accelerates cognitive decline. A new study in eNeuro by Babak…
-
CBD and Alzheimer’s: Combatting Neuroinflammation in Mice
Understanding the link between neuroinflammation and Alzheimer’s Neuroinflammation is increasingly recognized as a pivotal driver of neuronal damage in Alzheimer’s disease. While much attention has centered on amyloid plaques and tau tangles, chronic immune activation within the brain—often driven by microglia and other glial cells—can accelerate neurodegeneration. A growing body of work suggests that modulating…
-
7 Early Signs Your Brain Is Aging Too Fast, Reveals a Longevity Expert
Introduction: Why watching the brain matters As we age, our bodies show wear. Yet the brain often signals trouble first, signaling the need for rest, nourishment, and cognitive care. Dr. Vassily Eliopoulos, a renowned longevity and brain health expert, identifies seven early warning signs that the brain may be aging faster than it should. Recognizing…
-
New findings tie Long COVID brain fog to AMPA receptor changes
Overview: Long COVID brain fog and a search for molecular clues Long COVID has emerged as one of the most persistent health challenges of the post-pandemic era. Among its most troubling consequences is cognitive impairment, commonly referred to as “brain fog,” which disrupts memory, attention, and problem-solving for many patients. While neuroimaging has revealed structural…
-
Unraveling Long COVID Brain Fog: AMPA Receptors Spotlighted by PET Imaging
New Molecular Insight into Long COVID Brain Fog As the world continues to grapple with the consequences of SARS-CoV-2 infection, Long COVID — a condition characterized by lingering symptoms after the acute illness — remains poorly understood. Among the most disabling manifestations is cognitive impairment, colloquially known as brain fog, which affects a significant portion…